Sandoz receives approval in Portugal for innovative respiratory inhaler AirFluSal® Forspiro®
Portuguese Health Authority grants marketing authorization for AirFluSal® Forspiro®Approval for 50-250 and 50-500µg dosage formsAirFluSal Forspiro already launched in four European countries and South KoreaHolzkirchen, October 09, 2014 – Sandoz announc…